Ethylene-vinyl acetate [EVA] infusion akpa ahịa: nnukwu ọchịchọ maka ihe ndị metụtara gburugburu ebe obibi na-akwalite mmepe ahịa

Dị ka akụkọ ahụ si kwuo, ahịa akpa infusion ethylene-vinyl acetate (EVA) zuru ụwa ọnụ bụ ihe dị ka nde US $ 128 na 2019, a na-atụkwa anya na ọ ga-eto eto na ọnụ ọgụgụ uto kwa afọ nke ihe dịka 7% site na 2020 ruo 2030. A na-atụ anya mmụba nke nri parenteral site na 2020 ruo 2030 nke ọrịa na-adịghị ala ala na ọrịa na-adịghị ala ala. kwalite mmepe nke ụwa ethylene-vinyl acetate (EVA) infusion akpa ahịa.
A na-atụ anya na n'oge amụma amụma, North America ga-aza ajụjụ maka oke dị mkpa nke ahịa akpa infusion ethylene-vinyl acetate (EVA) zuru ụwa ọnụ. Enwere ike ịpụta uto nke ahịa na mpaghara a n'ihi mmụba nke ọgwụ nje dị ka ọgwụ mgbochi, protein, ọgwụ mgbochi, plasma, enzymes, biologics na peptides maka ọgwụgwọ ọrịa kansa, ọrịa akwara ozi na ọrịa akụrụ na-adịghị ala ala. N'ime oge amụma, ịrị elu nke ọrịa ndụ, mmụba na mmefu ahụike na akụ na ụba siri ike nwere ike itinye aka na North America na-achị ahịa akpa infusion ethylene-vinyl acetate (EVA).
Rịọ mkpesa broshuọ-h​ttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79648
Site na 2020 ruo 2030, ahịa Eshia-Pacific na-atụ anya na ọ ga-eto na nnukwu mkpokọta uto kwa afọ nke 7.3%. Enwere ike ịsị nke a na mgbasawanye nke ụlọ ọrụ ahụike na mba ndị dị ka China, Japan na India. Na mgbakwunye, a na-atụ anya na mmepe na uto ahịa nke biopharmaceuticals na mba ndị dị ka Japan, India na China ga-ebuba ahịa na mpaghara a n'oge amụma.
Nri ndị nne na nna (PN) bụ nri a na-enye n'ime eriri afọ. Ọ nwere ike ikpokọta ihe ndị dị ka protein, starch, abụba, mineral, electrolytes, na vitamin, a na-ejikwa ya maka ndị ọrịa na-enweghị ike iri nri ma ọ bụ iri nri zuru oke. Ịmecha nnabata nri nri n'ụzọ ziri ezi nwere ike inyere aka ịlụso mgbagwoju anya ọgụ ma bụrụ akụkụ bụ isi nke mgbake ndị ọrịa. A na-akpọkwa nri ndị nne na nna mkpokọta nri parenteral (TPN). EVA nwere ihe ịga nke ọma na ogologo akụkọ ihe mere eme na ngwa parenteral. Ugbu a, a na-eji akpa EVA maka nnyefe eriri afọ nke ngụkọta nri parenteral (TPN). Tụkwasị na nke ahụ, a na-eji akpa EVA eme ihe maka nnyefe nne na nna nke mmiri mmiri mejupụtara. N'ozuzu, a na-eji ihe eji eme ihe ma ọ bụ ọgwụ na-ejikọta ọgwụ dị iche iche ọnụ. Dị ka ihe atụ, mmiri mmiri na-emepụta site na ịgwakọta nri parenteral na ọgwụ chemotherapy.
Arịrịọ iji nyochaa mmetụta COVID-19 na ahịa infusion ethylene-vinyl acetate (EVA) -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79648
Ebumnuche bụ isi nke nri ndị nne na nna bụ inye enyemaka nri zuru oke maka ndị ọrịa na-aga n'ihu na-arịa ọrịa. Ọnụ ọgụgụ dị elu nke etuto ọjọọ, ọrịa eriri afọ, ọrịa eriri afọ ischemic, nsogbu ọrịa shuga, na ọrịa Crohn na-atụgharị mmasị na nri parenteral. Dị ka Òtù Ahụ Ike Ụwa (WHO) si kwuo, ihe dị ka pasent 11 nke ọrịa ndị dị n'ụwa na-akpata n'ihi enweghị nri dị mma. N'ihi nchekwa oriri na-edozi ahụ na ọnọdụ gburugburu ebe obibi na-agbanwe, a na-atụ anya na pasent a ga-ebili n'ọdịnihu dị nso. Ya mere, mmasị na nri ndị nne na nna na-atụ anya na ọ gaghị agbanwe agbanwe. Ya mere, n'oge amụma, mmụba mmata banyere ọgwụgwọ nri nri parenteral nwere ike ịkwalite mmepe nke ahịa akpa infusion ethylene-vinyl acetate (EVA) zuru ụwa ọnụ.
N'ihe gbasara ụlọ, a na-ekewa ahịa akpa infusion ethylene-vinyl acetate (EVA) n'otu ọnụ ụlọ na ọtụtụ ọnụ ụlọ. A na-ejikarị akpa otu ọnụ ụlọ eme ihe maka ịgba ọgwụ mgbochi afọ, dị ka mmiri ịsa mmiri, akpa ntapu na mmiri na-adịghị mma. N'ihi ya, ọnụ ọgụgụ ojiji nke akpa otu oghere dị oke elu, nke a na-atụ anya ịkwalite mmepe nke mpaghara ahịa a n'oge amụma.
Arịrịọ nyocha ahaziri ahazi-https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79648
Dị ka ikike si dị, a na-ekewa ahịa akpa infusion ethylene-vinyl acetate (EVA) n'ime 50 ruo 150 ml, 150 ka 500 ml, 500 ruo 1,500 ml, 1,500 ruo 3,500 ml na ndị ọzọ (4,000 ml, 5,000 ml, wdg). N'ihi akpa 150 ruo 500 ml ka a na-eji ebute ụdị nri dị iche iche nke parenteral, yana mpaghara ahịa 150 ruo 500 ml ga-achịkwa ahịa akpa infusion ethylene-vinyl acetate (EVA) zuru ụwa ọnụ n'oge amụma.
N'ihe gbasara ndị ọrụ njedebe, ekewala ahịa akpa infusion ethylene-vinyl acetate (EVA) n'ụlọ ọgwụ, ụlọ ọgwụ na ebe ịwa ahụ. A na-eme atụmatụ na ka ọ na-erule 2030, ngalaba ụlọ ọgwụ ga-etinye oke dị mkpa na ahịa akpa infusion ethylene-vinyl acetate (EVA) zuru ụwa ọnụ. N'ihi na ojiji nke intravenous infusion, dialysis na minimally invasive endoscopic ịwa ahụ, ụlọ ọgwụ ngalaba na-achịkwa ụwa n'ahịa n'ihi na mma ụlọ ọrụ na akụrụngwa nyere ụlọ ọgwụ, preferential nkwụghachi ụgwọ atumatu, a zụrụ nke ọma ọrụ, na ọnụnọ nke ọkachamara na dọkịta na-awa , Onye ọrịa mmasị maka ụlọ ọgwụ.
Zụrụ ethylene vinyl acetate (EVA) infusion akpa akụkọ ahịa na https://www.transparencymarketresearch.com/checkout.php?rep_id=79648
Akụkọ ahụ na-enye nkọwapụta nke ụlọ ọrụ ndị na-eduga na-arụ ọrụ na ahịa akpa infusion ethylene vinyl acetate (EVA) zuru ụwa ọnụ. Ndị a gụnyere B. Braun Melsungen AG, ICU Medical, Inc., Baxter International, Inc., Fresenius Kabi AG, Technoflex, The Metrix Company, McKesson Medical-Surgical, Inc., AdvaCare Pharma, Valmed na Haemotronic.
Ahịa IT njikwa nkà mmụta ọgwụ: https://www.transparencymarketresearch.com/medical-talent-management-it-market.html
Ahịa sistemụ nnyefe ndị ọrịa na-enyere ikuku aka: https://www.transparencymarketresearch.com/air-assistant-patient-transfer-systems-market.html
Ahịa ọrụ ịkwụ ụgwọ ọgwụ: https://www.transparencymarketresearch.com/healthcare-payer-services-market.html
Nchọpụta ahịa nghọta bụ onye na-eweta ọgụgụ isi ahịa nke ọgbọ na-abịa nke na-enye ndị isi azụmaahịa, ndị na-ahụ maka ndụmọdụ na ndị ọkachamara usoro ihe ngwọta dabere na eziokwu.
Akụkọ anyị bụ otu ihe ngwọta maka uto azụmahịa, mmepe na ntozu okè. Usoro nnakọta data anyị ozugbo yana ikike iji soro ngwaahịa niche karịrị nde 1 na-eto eto na-emezu ebumnuche gị. Ụdị ndekọ ọnụ ọgụgụ zuru ezu na nke nwe ya nke ndị nyocha anyị na-eji na-enye nghọta maka ime mkpebi ziri ezi n'oge kacha nso enwere ike. Maka otu ndị chọrọ ozi akọwapụtara mana nke zuru oke, anyị na-enye azịza ahaziri iche site na mkpesa ad hoc. A na-enyefe arịrịọ ndị a site na nchikota zuru oke nke ụzọ edozi nsogbu gbadoro anya nke ọma yana iji ebe nchekwa data dị.
TMR kwenyere na nchikota ngwọta maka nsogbu ndị ahịa kpọmkwem na ụzọ nyocha ziri ezi bụ isi ihe na-enyere ụlọ ọrụ aka ime mkpebi ziri ezi.
Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY-12207 United States of America-Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www. transparencymarketresearch.com /